Has Francis Langford, MD received payments from drug or device companies?

Yes. Drug and device makers reported $2,163 in general payments to Francis Langford, MD across 76 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Francis Langford, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Francis Langford, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Francis Langford, MD

Facial Plastic Surgery · Concord, NCNPI 1952348492

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 76 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 20 manufacturers reported payments, led by Sanofi at 27.0% of the total.

$2,163in general payments, 2019–2025

Across 76 payments — averaging $28.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Sanofi$585
Stryker$244
GSK$233
Aerin Medical Inc.$213
Neurent Medical Limited$161
Medtronic$161
plus $566 from 14 others

$16,275in research payments, 2019–2025

Across 10 payments — averaging $1627.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Intersect ENT, Inc.$9K
Aerin Medical Inc.$6K
Stryker$2K

What the payments were for

Food & beverage$2,163100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Sanofi	19	$585
Stryker	6	$244
GSK	16	$233
Aerin Medical Inc.	8	$213
Neurent Medical Limited	2	$161
Medtronic	2	$161
Regeneron Healthcare Solutions, Inc.	2	$151
Hikma Pharmaceuticals USA	7	$116
Optinose US, Inc.	1	$97
AstraZeneca	2	$42
Acclarent, Inc	2	$30
Genentech USA, Inc.	1	$21
Aytu Biopharma, Inc.	1	$19
Phathom Pharmaceuticals, Inc.	1	$18
Merck	1	$16
Integra Lifesciences Corporation	1	$14
Cochlear Americas	1	$14
Intersect ENT, Inc.	1	$13
Peerless Surgical Inc.	1	$12
Forte Bio-pharma LLC	1	$3

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

DUPIXENT$377
NEUROMARK Device$140
NEUROMARK Radiofrequency Generator$140
PROPEL$137
ENTELLUS - XPRESS ENT DILATION SYSTEM$137
VIVAER STYLUS$109
RHINAER STYLUS$109

How this compares

Too few facial plastic surgery providers in North Carolinato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024

$207,100

Medicare patients

434

Services billed

1,494

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Mometasone Furoate	50	$3,986
Ipratropium Bromide	137	$3,403
Fluticasone Propionate	241	$3,238
Azelastine Hcl	117	$3,180
Cefdinir	76	$1,613
Mupirocin	118	$1,298
Omeprazole	65	$1,150
Fluocinolone Acetonide Oil	26	$881
Ofloxacin	31	$682
Doxycycline Monohydrate	21	$340
Prednisone	127	$338
Cephalexin	53	$278
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav	26	$251
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	47	$225
Montelukast Sodium	19	$188

Paid to pharmacies, not to this prescriber.

Other facial plastic surgery in Concord

Robert JarchowConcord$43
Jeffrey CouryWhiteville$4K
Erik KenyonWhiteville$4K
James DimuzioWhiteville$3K
Jefferson KilpatrickPinehurst$764
Andrea GarciaCharlotte$690
Richard PollockRocky Mount$333
Neal GoldmanBoone$34

See the full list for North Carolina →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →